{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:05:00Z","timestamp":1780635900641,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,4]]},"DOI":"10.7759\/cureus.110274","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:45:47Z","timestamp":1780634747000},"source":"Crossref","is-referenced-by-count":0,"title":["Effect of Tumor Stage and Molecular Subtypes on Five-Year Overall Survival in Breast Cancer: A Single-Center Study From Pakistan"],"prefix":"10.7759","author":[{"given":"Mohammad A","family":"Sahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul S","family":"Waqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anam","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannat","family":"Asif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Waqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Rasul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.36255\/exon-publications-breast-cancer-subtypes","article-title":"Subtypes of breast cancer","author":"Orrantia-Borunda E","year":"2022","unstructured":"Orrantia-Borunda E, Anchondo-Nu\u00f1ez P, Acu\u00f1a-Aguilar LE, G\u00f3mez-Valles FO, Ram\u00edrez-Valdespino CA. Subtypes of breast cancer. Breast Cancer. Mayrovitz HN (ed): Exon Publications, Brisbane, AU; 2022. 10.36255\/exon-publications-breast-cancer-subtypes"},{"key":"ref2","unstructured":"National Cancer Institute. SEER Cancer Stat Facts. Female breast cancer subtypes. (2026). Accessed. February 16, 2026: https:\/\/seer.cancer.gov\/statfacts\/html\/breast-subtypes.html."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00864","article-title":"Breast cancer survivorship, quality of life, and late toxicities","volume":"10","author":"Nardin S","year":"2020","unstructured":"Nardin S, Mora E, Varughese FM, et al.. Breast cancer survivorship, quality of life, and late toxicities. Front Oncol. 2020, 10:864. 10.3389\/fonc.2020.00864","journal-title":"Front Oncol"},{"key":"ref4","unstructured":"American Cancer Society. Cancer Facts & Figures 2025. (2025). Accessed. February 16, 2026: https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/2025-cancer-facts-figures.html."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.29271\/jcpsp.2023.06.625","article-title":"National Cancer Registry of Pakistan: First Comprehensive Report of Cancer Statistics 2015-2019","volume":"33","author":"Ikram A","year":"2023","unstructured":"Ikram A, Pervez S, Khadim MT, et al.. National Cancer Registry of Pakistan: First Comprehensive Report of Cancer Statistics 2015-2019. J Coll Physicians Surg Pak. 2023, 33:625-32. 10.29271\/jcpsp.2023.06.625","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-021-01293-6","article-title":"Fears and barriers: problems in breast cancer diagnosis and treatment in Pakistan","volume":"21","author":"Saeed S","year":"2021","unstructured":"Saeed S, Asim M, Sohail MM. Fears and barriers: problems in breast cancer diagnosis and treatment in Pakistan. BMC Womens Health. 2021, 21:151. 10.1186\/s12905-021-01293-6","journal-title":"BMC Womens Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S180388","article-title":"Identifying the reasons for delayed presentation of Pakistani breast cancer patients at a tertiary care hospital","volume":"11","author":"Gulzar F","year":"2019","unstructured":"Gulzar F, Akhtar MS, Sadiq R, Bashir S, Jamil S, Baig SM. Identifying the reasons for delayed presentation of Pakistani breast cancer patients at a tertiary care hospital. Cancer Manag Res. 2019, 11:1087-96. 10.2147\/CMAR.S180388","journal-title":"Cancer Manag Res"},{"key":"ref8","unstructured":"National Cancer Institute. SEER Cancer Stat Facts. Female breast cancer. (2026). Accessed. February 16, 2026: https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcpo.2021.100285","article-title":"The global landscape of availability, accessibility and affordability of essential diagnostics and therapeutics for the management of HER2-positive breast cancer: the ONCOLLEGE-001 survey","volume":"28","author":"Trapani D","year":"2021","unstructured":"Trapani D, Lengyel CG, Habeeb BS, et al.. The global landscape of availability, accessibility and affordability of essential diagnostics and therapeutics for the management of HER2-positive breast cancer: the ONCOLLEGE-001 survey. J Cancer Policy. 2021, 28:100285. 10.1016\/j.jcpo.2021.100285","journal-title":"J Cancer Policy"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00288-6","article-title":"Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13\u2008864 women in seven randomised trials","volume":"22","year":"2021","unstructured":"Trastuzumab for early-stage, HER2-positive breast cancer. a meta-analysis of 13\u2008864 women in seven randomised trials. Lancet Oncol. 2021, 22:1139-50. 10.1016\/S1470-2045(21)00288-6","journal-title":"Lancet Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1413513","article-title":"Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer","volume":"372","author":"Swain SM","year":"2015","unstructured":"Swain SM, Baselga J, Kim SB, et al.. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. N Engl J Med. 2015, 372:724-34. 10.1056\/NEJMoa1413513","journal-title":"N Engl J Med"},{"key":"ref12","unstructured":"World Health Organization. Informal dialogue. access to essential medicines and technologies for breast cancer. (2024). Accessed: February 16, 2026: https:\/\/www.who.int\/news-room\/events\/detail\/2024\/09\/18\/default-calendar\/the-global-breast-cancer-initiative---an-info...."},{"key":"ref13","article-title":"","author":"Sohaib M","year":"2019","unstructured":"Sohaib M, Shafiq A. PAEC Cancer Registry Report 2018-2019. Atomic Energy Cancer Hospitals, Cancer Care Network, Pakistan. Pakistan Atomic Energy Commission, Islamabad, Pakistan; 2019. https:\/\/paec.gov.pk\/Documents\/Medical\/PAECR_report_2018-19.pdf."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.5534","article-title":"Screening for breast cancer: US Preventive Services Task Force Recommendation Statement","volume":"331","author":"Nicholson WK","year":"2024","unstructured":"Nicholson WK, Silverstein M, Wong JB, et al.. Screening for breast cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2024, 331:1918-30. 10.1001\/jama.2024.5534","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n256","article-title":"Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai","volume":"372","author":"Mittra I","year":"2021","unstructured":"Mittra I, Mishra GA, Dikshit RP, et al.. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai. BMJ. 2021, 372:n256. 10.1136\/bmj.n256","journal-title":"BMJ"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/497025-effect-of-tumor-stage-and-molecular-subtypes-on-five-year-overall-survival-in-breast-cancer-a-single-center-study-from-pakistan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:46:06Z","timestamp":1780634766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/497025-effect-of-tumor-stage-and-molecular-subtypes-on-five-year-overall-survival-in-breast-cancer-a-single-center-study-from-pakistan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.110274","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,4]]}}}